drugset / Trial / NCT01364064
Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
Phase 3
Completed
1153 enrolled
King Faisal Specialist Hospital & Research Center
Radiation Therapy Oncology Group · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | — | — |